EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Preliminary results of CAR-T–based consolidation with or without ASCT for patients with relapsed/refractory large B-cell lymphoma in complete remission after salvage therapy

Fei Xue, Rui Liu, Huazhou Shi, Hui Shi, Fan Yang, Lixia Ma, Peihao Zheng, Shaomei Feng, Yuelu Guo, Zhonghua Fu, Biping Deng, Xiaoyan Ke und 1 weitere

Cancer Immunology, Immunotherapy · 20.08.2026 · 75 (12)

DOI: 10.1007/s00262-026-04525-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 20.08.2026. Verfasst von Fei Xue und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China. Hauptthemen laut MEDLINE: Salvage Therapy, Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salvage TherapyImmunotherapy, AdoptiveLymphoma, Large B-Cell, DiffuseHematopoietic Stem Cell TransplantationNeoplasm Recurrence, LocalHumansFemaleMaleMiddle AgedRetrospective StudiesAdultRemission InductionAgedTransplantation, AutologousPathologic Complete ResponseConsolidation Chemotherapy

Stichwörter der Autor:innen

Aggressive refractory or relapsed large B-cell lymphomaChimeric antigen receptor T cell therapyConsolidation therapy

Autor:innen und Institutionen

  • Department of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China.
  • Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Cytology Laboratory, Beijing GoBroad Boren Hospital, Beijing, China.
  • Department of Lymphoma and Myeloma Research Center, Beijing GoBroad Hospital, Beijing, China. huk@gobroadhealthcare.com.

Zitieren

APA

Xue, F., Liu, R., Shi, H., Shi, H., Yang, F., Ma, L., Zheng, P., Feng, S., Guo, Y., Fu, Z., Deng, B., Ke, X., & Hu, K. (2026). Preliminary results of CAR-T–based consolidation with or without ASCT for patients with relapsed/refractory large B-cell lymphoma in complete remission after salvage therapy. Cancer Immunology, Immunotherapy, 75(12). https://doi.org/10.1007/s00262-026-04525-6

Vancouver

Xue F, Liu R, Shi H, Shi H, Yang F, Ma L, et al. Preliminary results of CAR-T–based consolidation with or without ASCT for patients with relapsed/refractory large B-cell lymphoma in complete remission after salvage therapy. Cancer Immunology, Immunotherapy. 2026;75(12). doi:10.1007/s00262-026-04525-6

BibTeX
@article{Xue2026,
  author = {Xue, Fei and Liu, Rui and Shi, Huazhou and Shi, Hui and Yang, Fan and Ma, Lixia and Zheng, Peihao and Feng, Shaomei and Guo, Yuelu and Fu, Zhonghua and Deng, Biping and Ke, Xiaoyan and Hu, Kai},
  title = {Preliminary results of CAR-T–based consolidation with or without ASCT for patients with relapsed/refractory large B-cell lymphoma in complete remission after salvage therapy},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {12},
  doi = {10.1007/s00262-026-04525-6}
}
Kostenlos starten →